Literature DB >> 20941606

DCs in immune tolerance in steady-state conditions.

Tomohiro Fukaya1, Hideaki Takagi, Honami Taya, Katsuaki Sato.   

Abstract

Dendritic cells (DCs) are antigen-presenting cells (APCs) characterized by a unique capacity to stimulate naïve T cells and initiate primary immune responses. Recent studies suggest that DCs are also involved in the induction of immunological tolerance in peripheral tissues under steady-state conditions by maintaining the homeostasis of self-reactive CD4(+)Foxp3(+)naturally occurring thymic-derived regulatory T cells (nT(regs)) and de novo generation of antigen-specific CD4(+)Foxp3(+)inducible regulatory T cells (iT(regs)). We demonstrate here the impact of CD11(+)DCs on the antigen-specific differentiation of CD4(+)Foxp3(+)iT(regs) from CD4(+)Foxp3(-)T cells under steady-state and inflammatory conditions. CD11c(+)DCs promoted the transforming growth factor (TGF)-β1-mediated conversion of CD4(+)Foxp3(-)T cells into CD4(+)Foxp3(+)iT(regs) in vitro, while stimulation of CD11c(+)DCs with CpG oligodeoxynucleotide (ODN) abrogated this conversion. Furthermore, antigen-specific generation of CD4(+)Foxp3(+)iT(regs) required the function of CD11(+)DCs under steady-state conditions, whereas such conversion was severely abolished under inflammatory conditions. Thus, these results suggest the crucial role of DCs in the antigen-specific de novo conversion of CD4(+)Foxp3(-)T cells into CD4(+)Foxp3(+)iT(regs) under steady-state conditions, thereby leading to the establishment of peripheral immune tolerance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20941606     DOI: 10.1007/978-1-60761-869-0_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Adoptive transfer of dendritic cells expressing CD11c reduces the immunological response associated with experimental colitis in BALB/c mice.

Authors:  Lisiery N Paiatto; Fernanda G D Silva; Áureo T Yamada; Wirla M S C Tamashiro; Patricia U Simioni
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.240

2.  Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.

Authors:  Wattawan Wongpattaraworakul; Katherine N Gibson-Corley; Allen Choi; Marisa R Buchakjian; Emily A Lanzel; Anand Rajan Kd; Andrean L Simons
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

3.  Tolerogenic vaccines for Multiple sclerosis.

Authors:  Mark D Mannie; Alan D Curtis
Journal:  Hum Vaccin Immunother       Date:  2013-01-28       Impact factor: 3.452

Review 4.  Regulatory dendritic cells for immunotherapy in immunologic diseases.

Authors:  John R Gordon; Yanna Ma; Laura Churchman; Sara A Gordon; Wojciech Dawicki
Journal:  Front Immunol       Date:  2014-01-31       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.